World's Best Scientists 2026 revealed!
John Kjekshus

John Kjekshus

D-Index & Metrics

Medicine

D-Index
108
Citations
96237
World Ranking
5852
National Ranking
19

John Kjekshus publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John Kjekshus sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 395 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John Kjekshus D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John Kjekshus sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John Kjekshus is affiliated with the University of Oslo in Norway and has contributed to the field of medicine with a focus on several subfields including surgery, endocrinology, diabetes and metabolism, genetics, emergency medicine, and economics and econometrics.

Their research spans key topics such as:

  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • HIV-related health complications and treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Genomics and Rare Diseases
  • Genetics and Neurodevelopmental Disorders
  • Cardiomyopathy and Myosin Studies

Frequent coauthors include Christina Reith, Colin Baigent, Lisa Blackwell, Jonathan Emberson, and Enti Spata.

The publication venues where they have contributed most often include:

  • Tidsskrift for Den norske legeforening
  • The Lancet
  • The Lancet Diabetes & Endocrinology
  • JAMA Cardiology

Recent papers authored or coauthored by John Kjekshus cover diverse aspects of medicine and cardiovascular health. These include:

  • "Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials" (2022, The Lancet)
  • "Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis" (2024, The Lancet Diabetes & Endocrinology)
  • "Assessing the Role of Rare Genetic Variation in Patients With Heart Failure" (2020, JAMA Cardiology)
  • "Halfdan Ihlen" (2022, Tidsskrift for Den norske legeforening)
  • "Kolbjørn Forfang" (2022, Tidsskrift for Den norske legeforening)

Best Publications

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    A.G. Olsson;J McMurray;G Thorgeirsson;C Spaulding

  • Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

    Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman

  • Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)

    Karl Swedberg;John Kjekshus

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆

    Alberico L. Catapano;Zeljko Reiner;Guy De Backer;Ian Graham

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

    Pyŏrälä K;Pedersen Tr;Kjekshus J;Faergeman O

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Rosuvastatin in Older Patients with Systolic Heart Failure

    John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm

  • Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions

    Peter R. Maroko;John K. Kjekshus;Burton E. Sobel;Tan Watanabe

  • Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial

    Kenneth Dickstein;John Kjekshus

  • Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

    K Swedberg;P Eneroth;J Kjekshus;L Wilhelmsen

  • Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

    Karl Swedberg;Peter Held;John Kjekshus;Knut Rasmussen

  • ESC/EAS Guidelines for the management of dyslipidaemias

    Alberico L. Catapano;Željko Reiner;Guy De Backer;Ian Graham

  • Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

    Terje R. Pedersen;Anders G. Olsson;Ole Færgeman;John Kjekshus

  • HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

    R. Haynes;L. Jiang;J. C. Hopewell;J Li

  • Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials

    M G Franzosi;E Santoro;G Zuanetti;C Baigent

  • The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

    Cynthia J Girman;Thomas Rhodes;Michele Mercuri;Kalevi Pyörälä

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    Terje R Pedersen

Frequent Co-Authors

Lars Gullestad
Lars Gullestad Oslo University Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Thor Ueland
Thor Ueland University of Oslo
Pål Aukrust
Pål Aukrust Oslo University Hospital
Kenneth Dickstein
Kenneth Dickstein University of Bergen
Hans Wedel
Hans Wedel University of Gothenburg
John G.F. Cleland
John G.F. Cleland University of Glasgow
Terje R. Pedersen
Terje R. Pedersen Oslo University Hospital
Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Stig S. Frøland
Stig S. Frøland University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, there are several related online programs that can help accelerate your journey or broaden your opportunities. For those wishing to enter healthcare quickly, fast track LPN programs allow you to become a Licensed Practical Nurse in less time than traditional routes. This can be a great starting point for hands-on clinical experience.

If mental health interests you, the demand for nurse practitioners is growing rapidly. Earning your credentials via online PMHNP programs can lead to specialized roles in psychiatric care, all while studying remotely.

Prefer to work on the administrative side of healthcare? A healthcare administration degree online provides flexible training in management, policy, and leadership. For advanced positions, consider one of the most affordable online MHA programs to gain a master’s-level qualification without breaking the bank.

Best Scientists Citing John Kjekshus

Trending Scientists

Recently Published Articles